Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus challenges

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Vaccine

Topics

Biology

Epidemiology

Immunology

Infectious Diseases

Receptor

Show all topics

DOI

10.1016/j.vaccine.2024.126585